vs
孩之宝（HAS）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
孩之宝的季度营收约是Revvity的1.9倍（$1.4B vs $772.1M），孩之宝净利率更高（13.9% vs 12.7%，领先1.2%），孩之宝同比增速更快（31.3% vs 5.9%），孩之宝自由现金流更多（$389.5M vs $161.8M），过去两年孩之宝的营收复合增速更高（38.2% vs 9.0%）
孩之宝是1923年12月6日成立的美国跨国玩具制造与娱乐控股企业，总部位于罗德岛州波塔基特。旗下拥有Kenner、米尔顿·布拉德利、派克兄弟、威世智等知名品牌，持有大量热门IP商标权，业务覆盖玩具生产、游戏开发、娱乐内容出品等多个领域。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HAS vs RVTY — 直观对比
营收规模更大
HAS
是对方的1.9倍
$772.1M
营收增速更快
HAS
高出25.4%
5.9%
净利率更高
HAS
高出1.2%
12.7%
自由现金流更多
HAS
多$227.7M
$161.8M
两年增速更快
HAS
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $772.1M |
| 净利润 | $201.6M | $98.4M |
| 毛利率 | 68.7% | — |
| 营业利润率 | 20.6% | 14.5% |
| 净利率 | 13.9% | 12.7% |
| 营收同比 | 31.3% | 5.9% |
| 净利润同比 | 687.8% | 3.9% |
| 每股收益（稀释后） | $1.46 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HASRVTY
| Q4 25 | $1.4B | $772.1M | ||
| Q3 25 | $1.4B | $698.9M | ||
| Q2 25 | $980.8M | $720.3M | ||
| Q1 25 | $887.1M | $664.8M | ||
| Q4 24 | $1.1B | $729.4M | ||
| Q3 24 | $1.3B | $684.0M | ||
| Q2 24 | $995.3M | $691.7M | ||
| Q1 24 | $757.3M | $649.9M |
净利润HASRVTY
| Q4 25 | $201.6M | $98.4M | ||
| Q3 25 | $233.2M | $46.7M | ||
| Q2 25 | $-855.8M | $53.9M | ||
| Q1 25 | $98.6M | $42.2M | ||
| Q4 24 | $-34.3M | $94.6M | ||
| Q3 24 | $223.2M | $94.4M | ||
| Q2 24 | $138.5M | $55.4M | ||
| Q1 24 | $58.2M | $26.0M |
毛利率HASRVTY
| Q4 25 | 68.7% | — | ||
| Q3 25 | 70.1% | 53.6% | ||
| Q2 25 | 77.0% | 54.5% | ||
| Q1 25 | 76.9% | 56.5% | ||
| Q4 24 | 67.4% | — | ||
| Q3 24 | 70.4% | 56.3% | ||
| Q2 24 | 76.1% | 55.7% | ||
| Q1 24 | 73.0% | 54.6% |
营业利润率HASRVTY
| Q4 25 | 20.6% | 14.5% | ||
| Q3 25 | 24.6% | 11.7% | ||
| Q2 25 | -81.4% | 12.6% | ||
| Q1 25 | 19.2% | 10.9% | ||
| Q4 24 | 5.4% | 16.3% | ||
| Q3 24 | 23.6% | 14.3% | ||
| Q2 24 | 21.3% | 12.4% | ||
| Q1 24 | 15.3% | 6.8% |
净利率HASRVTY
| Q4 25 | 13.9% | 12.7% | ||
| Q3 25 | 16.8% | 6.7% | ||
| Q2 25 | -87.3% | 7.5% | ||
| Q1 25 | 11.1% | 6.4% | ||
| Q4 24 | -3.1% | 13.0% | ||
| Q3 24 | 17.4% | 13.8% | ||
| Q2 24 | 13.9% | 8.0% | ||
| Q1 24 | 7.7% | 4.0% |
每股收益（稀释后）HASRVTY
| Q4 25 | $1.46 | $0.86 | ||
| Q3 25 | $1.64 | $0.40 | ||
| Q2 25 | $-6.10 | $0.46 | ||
| Q1 25 | $0.70 | $0.35 | ||
| Q4 24 | $-0.25 | $0.77 | ||
| Q3 24 | $1.59 | $0.77 | ||
| Q2 24 | $0.99 | $0.45 | ||
| Q1 24 | $0.42 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $565.5M | $7.3B |
| 总资产 | $5.6B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HASRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
股东权益HASRVTY
| Q4 25 | $565.5M | $7.3B | ||
| Q3 25 | $433.8M | $7.4B | ||
| Q2 25 | $269.7M | $7.6B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.7B | ||
| Q3 24 | $1.3B | $7.9B | ||
| Q2 24 | $1.2B | $7.9B | ||
| Q1 24 | $1.0B | $7.8B |
总资产HASRVTY
| Q4 25 | $5.6B | $12.2B | ||
| Q3 25 | $5.5B | $12.1B | ||
| Q2 25 | $5.2B | $12.4B | ||
| Q1 25 | $6.0B | $12.4B | ||
| Q4 24 | $6.3B | $12.4B | ||
| Q3 24 | $7.2B | $12.8B | ||
| Q2 24 | $6.9B | $13.4B | ||
| Q1 24 | $6.2B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $403.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $389.5M | $161.8M |
| 自由现金流率自由现金流/营收 | 26.9% | 21.0% |
| 资本支出强度资本支出/营收 | 0.9% | 2.6% |
| 现金转化率经营现金流/净利润 | 2.00× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $829.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流HASRVTY
| Q4 25 | $403.2M | $182.0M | ||
| Q3 25 | $280.6M | $138.5M | ||
| Q2 25 | $71.3M | $134.3M | ||
| Q1 25 | $138.1M | $128.2M | ||
| Q4 24 | $259.8M | $174.2M | ||
| Q3 24 | $222.5M | $147.9M | ||
| Q2 24 | $187.3M | $158.6M | ||
| Q1 24 | $177.8M | $147.6M |
自由现金流HASRVTY
| Q4 25 | $389.5M | $161.8M | ||
| Q3 25 | $260.9M | $120.0M | ||
| Q2 25 | $55.2M | $115.5M | ||
| Q1 25 | $124.3M | $112.2M | ||
| Q4 24 | $200.8M | $149.8M | ||
| Q3 24 | $174.0M | $125.6M | ||
| Q2 24 | $135.4M | $136.6M | ||
| Q1 24 | $132.0M | $129.7M |
自由现金流率HASRVTY
| Q4 25 | 26.9% | 21.0% | ||
| Q3 25 | 18.8% | 17.2% | ||
| Q2 25 | 5.6% | 16.0% | ||
| Q1 25 | 14.0% | 16.9% | ||
| Q4 24 | 18.2% | 20.5% | ||
| Q3 24 | 13.6% | 18.4% | ||
| Q2 24 | 13.6% | 19.7% | ||
| Q1 24 | 17.4% | 20.0% |
资本支出强度HASRVTY
| Q4 25 | 0.9% | 2.6% | ||
| Q3 25 | 1.4% | 2.6% | ||
| Q2 25 | 1.6% | 2.6% | ||
| Q1 25 | 1.6% | 2.4% | ||
| Q4 24 | 5.4% | 3.4% | ||
| Q3 24 | 3.8% | 3.3% | ||
| Q2 24 | 5.2% | 3.2% | ||
| Q1 24 | 6.0% | 2.7% |
现金转化率HASRVTY
| Q4 25 | 2.00× | 1.85× | ||
| Q3 25 | 1.20× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 1.40× | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 1.00× | 1.57× | ||
| Q2 24 | 1.35× | 2.87× | ||
| Q1 24 | 3.05× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HAS
| Grow Brands | $1.1B | 75% |
| Optimize Brands | $188.7M | 13% |
| Digital And Licensing Gaming | $135.7M | 9% |
| Class Of Principal Product Family Brands | $13.1M | 1% |
| Filmand TV | $2.4M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
